Sulfuric Acid

Sulfuric Acid

SCHEMBL3125331

COc1ccc(CNc2nc(CN)nc3ccccc23)cc1.O=S(=O)(O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.65
SLC2A1 P11166 1/20 0.55
ACHE P22303 3/20 0.55
POLB P06746 2/20 0.55
EGFR P00533 2/20 0.55
NR2F2 P24468 1/20 0.55
USP1 O94782 1/20 0.53
WDR48 Q8TAF3 1/20 0.53
NCF1 P14598 1/20 0.52
LMNA P02545 3/20 0.51
TP53 P04637 2/20 0.51
MAPT P10636 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPK1 P28482 2/20 0.49
USP2 O75604 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL92685 0.93 APP (0.73) APPSLC2A1ACHEPOLBEGFR
Hydrochloric Acid SCHEMBL3120955 0.92 APP (0.72) APPSLC2A1ACHEPOLBEGFR
SCHEMBL3106193 0.84 APP (0.70) APPSLC2A1ACHEPOLBEGFR
SCHEMBL3119160 0.84 APP (0.70) APPSLC2A1ACHEPOLBEGFR
SCHEMBL3110568 0.83 APP (0.71) APPSLC2A1ACHEPOLBEGFR
SCHEMBL3116114 0.82 APP (0.57) APPSLC2A1ACHEPOLBEGFR
SCHEMBL4864671 0.82 APP (0.70) APPSLC2A1ACHEPOLBEGFR
SCHEMBL3115914 0.82 APP (0.70) APPSLC2A1ACHEPOLBEGFR
SCHEMBL92716 0.82 APP (0.70) APPSLC2A1ACHEPOLBEGFR
SCHEMBL3110583 0.82 APP (0.70) APPSLC2A1ACHEPOLBEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100068197-A1 PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF MYRIAD PHARMACEUTICALS, INC. (US) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100068197-A1 PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF MKI67, CCNI, CCNA1 APP 3879/4885SLC2A1 337/4885ACHE 3644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.